ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Decision Diagnostics Corporation (CE)

Decision Diagnostics Corporation (CE) (DECN)

0,0001
0,0001
(9.900,00%)
Geschlossen 17 Januar 10:00PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,0001
Gebot
0,00
Fragen
0,00
Volumen
2.237.804
0,000001 Tagesbereich 0,0001
0,000001 52-Wochen-Bereich 0,0001
Handelsende
0,000001
Handelsbeginn
0,000001
Letzte Trade
836228
@
0.0001
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
99.234
Finanzvolumen
US$ 224
VWAP
0,0001

DECN Neueste Nachrichten

The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI)

  July 6, 2020 -- Investorshub NewsWire -- via Microcap Daily -- BY JACOB WATSON -- Alternet Systems, Inc. (OTCMKTS: ALYI) continues to see higher highs and higher lows...

DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology

DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology GenViroTM Anticipated to be Commercial Ready in Summer 2020...

DECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV...

DECN SETS PLAN TO MAKE UPCOMING PATENT INFRINGEMENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOVERY ++ COMPANY PLANS TO BUILD A FOUNDATION FOR...

DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAY

DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN NEXT 7 DAYS, CLINICAL TRIALS TESTING TO BEGIN IN MAY ++ EQUITY FUND IN STEALTHY MOVE TRIED TO GAIN...

DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE

DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE GOVERNMENT SHUTDOWN ++ COMPANY ALSO REACHES PRICING...

DECN DISCUSSES ITS GENULTIMATE! TBG SYSTEM, OFFERING ELITE PERFORMANCE AND PREMIER UPGRADE PATH FOR 4+ MILLION LIFESCAN USERS

  ++ COMPANY HAS ALSO AGREED TO MANUFACTURE A HOUSE BRAND PRODUCT FOR A “BIG BOX” AND WILL PROVIDE A FORECAST AND PRICE TERMS ONCE WE AGREE IN COMING DAYS ++ LOS...

DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court)

DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court)   ++ COMPANIES ANTICIPATE ANOTHER PRECEDENTIAL RULING FROM THE...

DECN ENGAGES SECOND KOREAN MANUFACTURING PARTNER TO RAISE ITS FACTORY CAPACITY TWO MILLION BOXES OF "GEN" TEST STRIPS ANNUALLY

++ COMPANY ALSO READIES IMMINENT APPEAL IN THE JOHNSON & JOHNSON PATENT INFRINGEMENT MATTER WITH THE U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT ++ Los Angeles, CA -- December 17, 2018...

DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATI...

DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATIONS ++ IP AND PRODUCTS STRATEGY IS PUT IN PLACE TO INCREASE...

DECN RECEIVES CLINICAL TRIALS REPORT, ANTICIPATES FILING ITS FDA 510K APPLICATION FOR ITS GENCHOICE! TEST STRIP ON 12/21/2018

++ DECN TO LAUNCH GENCHOICE! PRODUCT IN SELECT INTERNATIONAL MARKETS JANUARY 2, 2019 AND TO FILE FOR CE MARK IN THE EU AND HEALTH CANADA APPROVAL IN EARLY 2019 ++ Los Angeles, CA -- December 4...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
19.9E-599001.0E-60.00011.0E-6117641.0E-6CS
49.9E-599001.0E-60.00011.0E-61408151.0E-6CS
129.9E-599001.0E-60.00011.0E-6992341.0E-6CS
269.9E-599001.0E-60.00011.0E-6911961.0E-6CS
529.9E-599001.0E-60.00011.0E-6944141.0E-6CS
156-0.0025-96.15384615380.00260.00271.0E-61160740.00049994CS
260-0.0186-99.46524064170.01870.4971.0E-619995250.16282879CS

DECN - Frequently Asked Questions (FAQ)

What is the current Decision Diagnostics (CE) share price?
The current share price of Decision Diagnostics (CE) is US$ 0,0001
What is the 1 year trading range for Decision Diagnostics (CE) share price?
Decision Diagnostics (CE) has traded in the range of US$ 0,000001 to US$ 0,0001 during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ZTNOZoom Technologies Inc (CE)
US$ 0,005
(499.900,00%)
500
DOMWFPrime Drink Group Corporation (PK)
US$ 0,1408
(20.014,29%)
13,14k
DLAPQDelta Apparel Inc (CE)
US$ 0,0002
(19.900,00%)
250
LCDXCaliber Imaging and Diagnostics Inc (CE)
US$ 0,02
(19.900,00%)
30,86k
FPPPFieldpoint Petroleum Corp (CE)
US$ 0,000134
(13.300,00%)
150
HTRCHunter Creek Mining Co (CE)
US$ 0,000005
(-99,99%)
2k
VAGNFVegano Foods Inc (CE)
US$ 0,000001
(-99,97%)
3,18k
NKWFFOceanic Wind Energy Inc (CE)
US$ 0,00002
(-99,93%)
1.000
HXPNHarris Exploration Inc (CE)
US$ 0,000001
(-99,92%)
8k
SEANSAEAN Group Inc (PK)
US$ 0,01
(-99,67%)
100
PHILPHI Group Inc (PK)
US$ 0,0003
(50,00%)
938,4M
RDARRaadr Inc (PK)
US$ 0,0012
(4,35%)
202,33M
RONNRonn Motor Group Inc (PK)
US$ 0,0004
(0,00%)
179,66M
HCMCHealthier Choices Management Corporation (PK)
US$ 0,00005
(4.900,00%)
170,84M
HMBLHUMBL Inc (PK)
US$ 0,00095
(-5,00%)
155,67M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock